Iovance Biotherapeutics, Inc. · 8 hours ago
Medical Science Liaison - Central
Iovance Biotherapeutics is dedicated to advancing medical science, and they are seeking a Medical Science Liaison to provide clinical and scientific information about their products. The role involves building relationships with healthcare professionals and supporting clinical trial activities while enhancing the company's image in the medical community.
BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedical
Responsibilities
Enhance Iovance Biotherapeutics image as an advocate of medical advancement by using knowledge of product, disease state and pipeline products to engage healthcare providers in meaningful scientific exchange
Provides effective scientific and clinical presentations related to disease state(s) and Iovance products (approved and pipeline) to internal and external audiences with the capability to tailor presentations to meet specific audience needs
Identify, map, and profile key opinion leaders within territory to gain medical insights and evaluate potential opportunities for scientific collaboration
Develop and maintain successful relationships with healthcare professionals, clinical investigators, and providers in academic and non-academic settings to support scientific activities aligned with medical strategy including publications, advisory boards, and clinical trials
Collect and report field medical insights and intelligence using appropriate methods and platforms
Attend and provide scientific support of Medical Affairs activities and scientific sessions at key medical and scientific congresses/meetings/conferences
Build effective internal partnerships through collaboration and communication across the organization within Medical Affairs, Clinical Science, Clinical Operations, Market Access, and Commercial
Consistently demonstrate a positive, collaborative attitude that exemplifies ownership of business, partnership with key opinion leaders, teamwork with peers, and respect of supervisors, peers, and customers
Develop and prioritize solutions to problems, understand relationship between actions and results, and be able to understand and appreciate needs of the healthcare community
Possess an established medical/scientific background and a proven ability to effectively communicate complex scientific information
Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics
Perform miscellaneous duties as assigned
Qualification
Required
Advanced scientific degree (MD, PhD, PharmD) with a minimum of 3 years' relevant oncology experience
License (RN, NP, CNP, PA or equivalent) with a minimum of a Masters' degree or equivalent and a minimum of 5 years' relevant oncology experience
A minimum of 2 years' experience as an oncology MSL or comparable oncology industry role required
Competence in the following areas: Needs Assessment, Facilitation, Prioritization, Decision Making, Collaboration, Planning & Organizing, Implementation/Follow-up, Written and Verbal Communication
Meeting management skills and operational capabilities
Ability to perform under pressure and deadlines
Ability to work effectively within a matrix organization to achieve desired outcomes
Preferred
MSL (or relevant industry role) and clinical experience within oncology/immuno-oncology (solid tumor therapeutic areas of melanoma and/or lung cancer), and/or cellular therapy preferred
Knowledge of geography and key opinion leaders preferred
Understanding of regulatory requirements for field-based personnel
Demonstrated ability to present effective and influential oral presentations
Proven ability to coordinate across diverse functions, ensuring comprehensive and consistent planning
Experience managing project budgets and aligning with department strategic direction
Company
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
Funding
Current Stage
Public CompanyTotal Funding
$1.58B2024-02-20Post Ipo Equity· $211M
2023-07-10Post Ipo Equity· $150M
2020-05-27Post Ipo Equity· $603.7M
Leadership Team
Recent News
2025-12-29
2025-12-07
2025-11-11
Company data provided by crunchbase